Home » Newsletters » BioWorld Science

BioWorld Science

Feb. 24, 1997

View Archived Issues

NIH seeks licensees for antispasmodic immunotoxin

Licenses offered for vasospasm therapy

NIH seeks licensees for method of treating allergies and HIV

Method of treating allergies and HIV offered for licensing

NIH seeks licensees for therapeutic/diagnostic HAV receptor

Antiviral nucleoside analogues available for licensing

CD40 ligands and MAbs offered for licensing

NIH seeks licensees for cancer vaccines

Licensees sought for recombinant laminin receptors

Transcriptional cofactor offered by NIH

DNA sequencing technology available for licensing

Medco's cardiovascular evaluation agent receives European approval

Correlation between asthma and IL-10

Gene vaccination shows potential against allergy

Phase I results with rhIL-4 receptor

Long-term use of recombinant IFN-gamma evaluated

Acorda and Elan to collaborate on spinal cord injury treatment

GalaGen's Diffistat-G advances through phase I

Role of IL-5 in asthma

IL-15 enhancement of neonatal defenses

Merck's Fosamax earns recommendation

Combination beta-agonist/corticosteroid therapy beneficial in asthma

Novo Nordisk's growth hormone now available in 67 countries

Efficacy of hydoxychloroquine in asthma

Review date set for Sonus ultrasound contrast agent

CytoTherapeutics and Cognetix collaborate on CNS R&D

Provir progresses through clinical trials

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 21, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...